Journal
ONCOGENE
Volume 41, Issue 17, Pages 2520-2525Publisher
SPRINGERNATURE
DOI: 10.1038/s41388-022-02280-3
Keywords
-
Funding
- National Institutes of Health (NIH) [P01 CA140043, R35 CA220446, R50 CA211199]
- Mary Kay Foundation
Ask authors/readers for more resources
Hypoxic sEV generated by breast cancer cells can activate NF kappa B in normal mammary epithelial cells, leading to increased production and release of inflammatory cytokines, disrupted cell architecture, and promotion of oncogenic steps.
Small extracellular vesicles (sEV) contribute to the crosstalk between tumor cells and stroma, but the underlying signals are elusive. Here, we show that sEV generated by breast cancer cells in hypoxic (sEV(HYP)), but not normoxic (sEV(NORM)) conditions activate NF kappa B in recipient normal mammary epithelial cells. This increases the production and release of inflammatory cytokines, promotes mitochondrial dynamics leading to heightened cell motility and disrupts 3D mammary acini architecture with aberrant cell proliferation, reduced apoptosis and EMT. Mechanistically, Integrin-Linked Kinase packaged in sEV(HYP) via HIF1 alpha is sufficient to activate NF kappa B in the normal mammary epithelium, in vivo. Therefore, sEV(HYP) activation of NF kappa B drives multiple oncogenic steps of inflammation, mitochondrial dynamics, and mammary gland morphogenesis in a breast cancer microenvironment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available